HCA Healthcare’s (HCA) Overweight Rating Reiterated at Cantor Fitzgerald

HCA Healthcare (NYSE:HCA)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a note issued to investors on Monday,Benzinga reports. They currently have a $405.00 price objective on the stock. Cantor Fitzgerald’s target price would suggest a potential upside of 29.60% from the company’s current price.

Several other analysts have also recently commented on HCA. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Barclays lowered their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday. KeyCorp lowered their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price target for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $384.40.

HCA Healthcare Price Performance

NYSE:HCA opened at $312.51 on Monday. HCA Healthcare has a 12 month low of $279.93 and a 12 month high of $417.14. The company’s 50-day moving average price is $313.49 and its two-hundred day moving average price is $353.13. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $79.16 billion, a PE ratio of 14.03, a price-to-earnings-growth ratio of 1.09 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same period in the prior year, the business posted $5.90 earnings per share. On average, equities analysts anticipate that HCA Healthcare will post 21.75 EPS for the current fiscal year.

Insider Activity at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in HCA. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare during the third quarter valued at approximately $39,000. Canoe Financial LP bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $41,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the third quarter valued at about $41,000. Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $44,000. Finally, Pinnacle Bancorp Inc. increased its position in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.